Conference
A phase II multicenter study of stereotactic radiotherapy (SRT) for oligoprogression in metastatic renal cell cancer (mRCC) patients receiving tyrosine kinase inhibitor (TKI) therapy.
Authors
Cheung P; Patel S; North SA; Sahgal A; Chu W; Soliman H; Ahmad B; Winquist E; Patenaude F; Niazi T
Volume
38
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
May 20, 2020
Name of conference
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
ELECTR NETWORK
Conference start date
May 29, 2020
Conference end date
May 31, 2020
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X